Biologics Top Stories AlloSource Launches AlloMend Duo Acellular Dermal Matrix, A Natural Solution For Non-Directional Implantation In Soft Tissue Reconstruction byJosh SandbergMay 25, 2023
Biologics MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed – Acellular Human Reticular Dermal Allograft byJosh SandbergApril 17, 2023
Biologics Extremities AlloSource Launches Allomend Extra-large Acellular Dermal Matrix byJosh SandbergOctober 27, 2021
Biologics Sports Medicine Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix byChris StewartSeptember 9, 2021
Biologics Top Stories AlloSource Launches AlloMend Ultra-Thick Acellular Dermal Matrix byJosh SandbergAugust 11, 2021
Recon Sports Medicine Top Stories HSS Study: Good Outcomes After Arthroscopic Shoulder Superior Capsular Reconstruction byJosh SandbergAugust 12, 2020
Hospitals Integra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release byJosh SandbergMay 12, 2016
Biologics SpinalCyte, LLC Announces Final Results From Phase II Animal Trials Using Human Dermal Fibroblast Transplantation for Intervertebral Disc Degeneration byJosh SandbergApril 20, 2016
Extremities Integra LifeSciences Receives FDA Approval of Integra® Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU) byJosh SandbergJanuary 7, 2016